2020
DOI: 10.1016/j.biopha.2020.109945
|View full text |Cite
|
Sign up to set email alerts
|

Protection against acute cerebral ischemia/reperfusion injury by QiShenYiQi via neuroinflammatory network mobilization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
35
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 70 publications
(35 citation statements)
references
References 85 publications
0
35
0
Order By: Relevance
“…Recently, the major active ingredients in QSYQ, such as astragaloside IV, calycosin, calycosin-7-O-β-D-glycoside, formononetin, salvianolic acid A, salvianolic acid B, tanshinone IIA, notoginsenoside R1, ginsenoside Rg1, and ginsenoside Rb1 (Yu et al, 2017;Zhang et al, 2018), have been reported to have therapeutic potential in acute and subacute phases of ischemic stroke via various functional mechanisms, especially immune-inflammatory response related mechanism (Han et al, 2017b;Zhang et al, 2020). Furthermore, we have found the protective action of QSYQ against acute ischemic stroke via regulating neuroinflammatory network mobilization in a mouse model of cerebral ischemia and reperfusion (Wang et al, 2020).…”
Section: Introductionmentioning
confidence: 77%
See 1 more Smart Citation
“…Recently, the major active ingredients in QSYQ, such as astragaloside IV, calycosin, calycosin-7-O-β-D-glycoside, formononetin, salvianolic acid A, salvianolic acid B, tanshinone IIA, notoginsenoside R1, ginsenoside Rg1, and ginsenoside Rb1 (Yu et al, 2017;Zhang et al, 2018), have been reported to have therapeutic potential in acute and subacute phases of ischemic stroke via various functional mechanisms, especially immune-inflammatory response related mechanism (Han et al, 2017b;Zhang et al, 2020). Furthermore, we have found the protective action of QSYQ against acute ischemic stroke via regulating neuroinflammatory network mobilization in a mouse model of cerebral ischemia and reperfusion (Wang et al, 2020).…”
Section: Introductionmentioning
confidence: 77%
“…At present, QSYQ with the function of Qi-tonifying and blood-activating has been widely used to treat cardiovascular disease in clinic (Han et al, 2019). In addition to the cardioprotection against ischemia/reperfusion injury, we recently also reported the protective effect of pretreatment with QSYQ against CI/RI, which may be partly related to the modulation of neuroinflammatory response in an acute stroke model (Chen et al, 2015;Wang et al, 2020). However, questions remain on whether QSYQ contributes to the therapeutic post-stroke recovery and, if so, what the underlying mechanisms are.…”
Section: Discussionmentioning
confidence: 98%
“…Inflammation is a complex biological process in the body in response to cell and tissue damage (Chen et al, 2017). The definition of neuroinflammation is an inflammatory process within the brain or spinal cord (DiSabato et al, 2016;Wang Y. et al, 2020). Neuroinflammation is a common feature in many neurological diseases such as brain trauma, stroke, multiple sclerosis (MS), Alzheimer's disease (AD), and Parkinson's disease (PD) (Stephenson et al, 2018).…”
Section: Cellular and Molecular Responses To Brain Injuries Inflammatory Responsementioning
confidence: 99%
“…For example, the study from Wang B et al, which was totally cited 112 times, illustrated that low-concentration CO manifested a neuroprotective effect on cerebral ischemia by activating the Nrf2 pathway [27]. One of the special contributions of China was the exploration of the neuroprotective effect of traditional Chinese medicine, such as Sanhua Decoction and QiShenYiQi [28,29]. Many trials about neuroprotection failed to translate their protective effects from animal models to humans.…”
Section: The Research Trend Of Cerebrovascular Intervention In Chinamentioning
confidence: 99%